脂肪酸酰胺水解酶
阿那达胺
内大麻素系统
化学
大麻素受体
乙醇胺
大麻素
生物化学
十六酰胺乙醇
药理学
酶
水解酶
生物
受体
敌手
乙醇胺
作者
Ish Khanna,Christopher W. Alexander
出处
期刊:Cns & Neurological Disorders-drug Targets
[Bentham Science Publishers]
日期:2011-08-01
卷期号:10 (5): 545-558
被引量:27
标识
DOI:10.2174/187152711796234989
摘要
Fatty acid amide hydrolase (FAAH) is responsible for hydrolysis of endocannabinoid, anandamide (AEA), and N-acyl ethanolamines such as palmitoylethanolamine (PEA) and N-oleoylethanolamide (OEA). Genetic deletion or pharmacological inactivation of FAAH shows site-specific elevation of AEA that plays a role in the modulation of pain and other neurodegenerative disorders. The review elaborates recent progress and current status of diverse structural classes of reversible and irreversible FAAH inhibitors. The discussion also addresses ligand-enzyme active site interactions and mechanism of enzyme inactivation, emerging approaches to novel FAAH inhibitors, and ongoing efforts to address gaps in therapeutic utility of FAAH inhibitors. Keywords: N-Acyl ethanolamines, anandamide, N-arachidonylethanolamine, cannabinoid, endocannabinoid, fatty acid amide hydrolase, FAAH inhibitor, N-oleoylethanolamide, palmitoylethanolamine, Cannabis, MAFP, Activity Based Proten Profiling, KIAA1363
科研通智能强力驱动
Strongly Powered by AbleSci AI